Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: a systematic review
Authors:
Open Access
- 5 December 2013
- journal article
- review article
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 7 (11-12) , 463-470
Abstract
Introduction: We review the current evidence for the role of low-dose rate brachytherapy (PB) in patients with low- or intermediate-risk prostate cancer using a systematic review of the literature.Methods: We searched MEDLINE and EMBASE (from January 1996to October 2011), the Cochrane Library, relevant guideline websites, and websites for meetings specific for genitourinary diseases.Results: Ten systematic reviews and 55 single-study papers met the pre-planned study selection criteria. In the end, 36 articles were abstracted and analyzed for this systematic review. There is no evidence for a difference in efficacy between PB and external beam radiation therapy (EBRT), or between PB and radical prostatectomy (RP). During the 6 months to 3 years after treatment, PB was associated with less urinary incontinence and sexual impotency than RP, and RP was associated with less urinary irritation and rectal morbidity than PB. However, these differences diminished overtime. PB conferred less risk of impotency and rectal morbidity in the 3 years after treatment than EBRT. Iodine-125 and alladium-103 did not differ with respect to biochemical relapse-free survival and patient-reported outcomes.Conclusions: PB alone is a treatment option with equal efficacyto EBRT or RP alone in patients with newly diagnosed low- or intermediate-risk prostate cancer who require or choose active treatment.Keywords
This publication has 75 references indexed in Scilit:
- Quality of Life Among Men With Prostate Cancer in Rural GeorgiaUrology, 2011
- Permanent prostate seed brachytherapy: a current perspective on the evolution of the technique and its applicationNature Reviews Endocrinology, 2007
- I-125 Versus Pd-103 for Low-Risk Prostate CancerThe Cancer Journal, 2005
- Prospective Longitudinal Comparative Study of Health-Related Quality of Life in Patients Undergoing Invasive Treatments for Localized Prostate CancerJournal of Endourology, 2005
- Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: Data from CaPSUREInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Defining sexual outcomes after treatment for localized prostate carcinomaCancer, 2002
- Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancerCurrent Urology Reports, 2002
- Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.2001